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ABSTRACT
Sex determination and sexual differentiation are some of the most well studied topics in human
development. Sex determination is the point where the undifferentiated gonad becomes
committed to the ovarian or testicular pathway. This event can be triggered genetically or
environmentally. Sexual differentiation occurs after sexual determination and involves the
maturation of the gonad, which in turn, coordinates the corresponding physical and behavioral
phenotypes. Disorders of sexual development (DSD) are among the most common congenital
abnormalities seen in humans and are increasing at an alarming rate. Congenital DSDs can be
caused by genetic, hormonal, and/or environmental stimuli. Increased exposure to environmental
endocrine disrupters (EEDs) especially those that affect estrogen signaling have been shown to
cause DSDs. In addition to the mouse, the tammar wallaby, Macropus eugenii, has become a
novel model for studying gonadal differentiation in mammals. Unlike mice, sexual determination
and differentiation occurs postpartum in the tammar. Furthermore, pouch young are easily
accessible for surgical and hormonal manipulation. More is known about testicular
differentiation than ovarian differentiation. Thus, there is a substantial need to create
transcriptomes as a resource in discovering conserved and novel mechanisms in gonadal
development. This thesis explores the creation and analyses of these transcriptomes using normal
male and female developing gonads and estrogen induced ovarian development in male
marsupial gonads. It will also show that the tammar wallaby is a viable model for studying
gonadal differentiation and the effects of estrogen in sexual development in mammals.
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Introduction
Sex Determination and Sexual Differentiation
Sex determination and sexual differentiation are some of the best described aspects of human
development. Sex determination is the event that triggers an undifferentiated gonad to follow
either a male or female developmental pathway. The mechanisms for sex determination are
highly variable among the vertebrates and can be either triggered genetically or by
environmental conditions. Genetic sex determination (GSD) is when the undifferentiated gonad
depends on intrinsic genetic elements, such as a gene or chromosome to determine its trajectory,
where as environmental sex determination (ESD) depends on extrinsic environmental cues [1].
All mammals including humans have a genetic sex determining system, where a single gene on
the Y chromosome triggers male development. Sexual differentiation occurs following the sex
determination event and coordinates development of the mature gonad and the appropriate
urogenital and behavioral phenotype. Disorders of sexual development (DSD) arise when there
are problems associated with either the sex determination or sexual differentiation event and are
the most common congenital conditions in humans. DSDs can be caused by an abnormal
chromosomal complement, defective gonadal or anatomical development stemming from a
combination of genetic, hormonal, and/or environmental origins [2,3,4,5]. These disorders range
from Turner’s syndrome and Klinefelter’s syndrome to gonadal dysgenesis, cryptorchidism and
hypospadias [2,4].
Increasing cases of DSD have been linked to our increasing exposure to environmental endocrine
disrupters (EEDs). EEDs can be natural or synthetic chemicals that affect the endocrine system
and can be detrimental to human health especially the process of sexual differentiation. Exposure
of EEDs such as antiandrogens, estrogens and progestins particularly during pregnancy can
1

cause masculinization in females, feminization in males, decreased sperm count and cancer
[6,7,8]. For example, diethylstilbestrol (DES), a synthetic estrogen, was used by millions of
pregnant women during the 1940s to 1970s [6,7]. Exposure of DES to the fetus resulted in many
forms of DSD ranging from undescended testes, hypospadias, decreased sperm count, vaginal
hypoplasia, vaginal adenosis, infertility, and other reproductive issues. Additionally, exposure
increased risk of testicular cancer and clear cell vaginal adenocarcinoma [6,7]. The damaging
effects of EEDs are not only seen in humans but also in other mammals, fish, birds, reptiles,
amphibians and crustaceans. Similar effects of DES and other EEDs in humans have been
demonstrated in mice, rats, rabbits, goats and marsupials. There has been a rise of intersex fish
and frogs, increased mortality rate and decreased reproductive capacity in fish, birds and
alligators, and feminization of males and masculinization of females in birds and mollusks [8].
Thus, there is a great need to understand the impact these chemicals have on the molecular
pathways regulating normal sexual development.
The Marsupial Model
Many studies have been done utilizing mouse models especially knockout mice to explore
testicular and ovarian differentiation and the effects of estrogen on these systems. More recently
marsupial mammals like the gray short-tailed opossum, Monodelphis domestica, and the tammar
wallaby, Macropus eugenii, are becoming significant model species in the field of sexual
development. Similar to humans and other eutherian mammals, the tammar wallaby has a XY
genetic sex determining mechanism. The tammar diverged from humans around 130 to 148
million years ago [9,10]. Unlike the tammar wallaby, sexual differentiation in humans and other
eutherian mammals occurs in utero. However, the tammar wallaby gives birth to altricial young
where sexual differentiation and development occurs postnatally. Easy access to pouch young
2

allows for hormonal and surgical manipulation without the interference of the placenta
[10,11,12,13]. Many laboratories that use mice to study sexual differentiation have a difficult
time with hormonal administration due to placental metabolism of hormones. Moreover, sexual
differentiation occurs at a more rapid rate in utero in comparison to the tammar wallaby, and
germ cell and somatic cell development occurs simultaneously [1]. Even though mice reproduce
more rapidly, difficult and time consuming intrauterine surgery must occur to obtain access to
the fetuses. The tammar wallaby’s unique ability to give birth to altricial young allows for easy
sex reversal using estradiol and hormonal and surgical manipulation during significant
developmental time points [14]. All these factors make it advantageous to model DSD using the
tammar wallaby.
The majority of the key genes involved in sex determination and sexual differentiation in mice
have been investigated in marsupials [15,16,17]. While the current data suggests that there are
some differences in gene expression, the majority of genes behave in an identical manner in
establishing mouse and marsupial gonadal development. In both eutherian and marsupial
mammals, sex is determined by the Y-linked SRY gene. The presence of SRY triggers and
upregulates the expression of SOX9, Sry-type HMG box 9, in both eutherians and marsupials.
This in turn triggers the development of the testis and initiates the expression of AMH, AntiMüllerian hormone. Compared to eutherians, the marsupial X and Y chromosomes are relatively
small. The tammar X is homologous to the long arm and pericentric region of humans while the
tammar Y shares just four genes with the human Y [9,10].
Ovarian Development
Early research into sexual development including Alfred Jost’s pioneer experiment in rabbits in
the 1930s suggested that ovarian development was the default sexual developmental pathway. In
3

other words, if the gonad did not receive a dominant signal from the Y-chromosome (SRY) to
develop a testis, it would passively follow the developmental pathway of the ovary and
subsequently trigger female sexual development. This led to the Z-factor theory, which
hypothesizes that a single gene in the female gonad prevents testicular differentiation and
activates ovarian differentiation. However, recent research suggests otherwise and reveals the
presence of several pathways working in parallel pathways to coordinate female development.
R-spondin 1 (RSPO1) is part of the protein R-spondin family, which have been linked to various
developmental and oncogenic pathways. All R-spondins have an N-terminal signal peptide, two
furin repeats, one thrombospondin type 1 domain and a C-terminal domain with a nuclear
localization signal [18]. RSPO1 is particularly important in ovarian differentiation as it represses
testicular development by activating the canonical WNT/β-catenin signaling pathway [19]. In
humans, RSPO1 is located on chromosome 1p34.3 and mutations cause female-to-male sex
reversal, variations of testicular DSD, lack of Müllerian ducts, and palmoplantar hyperkeratosis
with squamous cell carcinoma of the skin [2,3,4,18,20,21]. Studies of Rspo1 KO in XX mice
exhibit partial female-to-male sex reversal with the formation of ovotestis and the presence of
both Wolffian and Müllerian ducts [18,19,22]. The Rspo1 KO gonad showed increased
expression of the testis markers Sox9, Amh, Fgf9, and Ptgds reiterating its role in suppressing
male development [22]. The presence of the Wolffian and Müllerian ducts in Rspo1 knockouts
suggests that RSPO1 is not involved in the development of the mesonephros, which is a
temporary kidney during embryogenesis and later becomes the Wolffian and Müllerian ducts. In
addition, it indicates the failure of Sertoli cell development since Amh is not fully produced to
regress the Müllerian ducts. Knockouts for both Rspo1 and Wnt4 resulted in the inactivation of
the WNT/β-catenin signaling pathway and the activation of β-catenin rescued Rspo1 KO mice
4

from phenotype mentioned above [18,19]. Deactivating any part of the WNT/β-catenin signaling
pathway results in female-to-male sex reversal and vice versa when activating the pathway in
males. During early development, RSPO1 expression levels were both low in male and female
wallabies until day 4 postpartum where levels increased in females and decreased in males. This
follows with ovarian differentiation occurring in the tammar on day 4. Results in tammar
wallaby were consistent with those in mice and humans except that RSPO1 could be acting
downstream of WNT4 and another ovarian gene FOXL2 [16].
Forkhead box L2 (FOXL2) is a forkhead/winged helix nuclear transcription factor that was first
discovered by studies on sex reversed XX goats with polled-intersex syndrome. This led to
FOXL2 being mapped to human chromosome 3q23 and associated with BlepharophimosisPtosis-Epicanthus Inversus Syndrome (BPES), premature ovarian failure (POF) and XX sterility.
Unlike in goats, FOXL2 mutations do not cause sex reversal in humans, but 1-3% of all women
are affected by POF [23,24,25]. FOXL2 is involved in primordial follicle development and
maintenance suggesting its relevance in ovarian morphogenesis and homeostasis during female
reproductive life [3,23,26,27,28,29]. Foxl2 mutations in XY mice have no effect on testis
differentiation, but overexpression inhibits testis formation [24,29]; however, any sort of Foxl2
mutation in XX mice causes partial female to male sex reversal, granulosa cells to convert into
sertoli-like cells, and the expression of genes involved in testicular development
[24,27,28,29,30,31]. Double loss of function mutations of Foxl2 with Wnt4 or Rspo1 still
resulted in partial sex reversal, but increased the masculinization of ovaries and boosted
expression of testis-specific genes including Sox9 [24,26]. The interaction between estrogen
receptor 1 and FOXL2 in mammals, including the tammar wallaby, represses the expression of
SOX9 through binding to the testis-specific enhancer of SOX9, TESCO [1,24,31]. Along with
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mice, female wallabies exhibit higher levels of FOXL2 than males suggesting its conserved role
in ovarian differentiation. During day 5 to 10 postpartum, FOXL2 was upregulated during
ovarian development in female wallabies. Estrogen exposure in male tammar wallabies resulted
in sex reversal, decreased expression of testis-specific genes SRY and AMH, lack of nuclear
SOX9, and increased expression of ovarian genes FOXL2 and WNT4 [16].
Wingless-type MMTV integration site family member 4 (WNT4) is part of a family of signaling
molecules that are involved in embryogenesis. In humans, WNT4 is located on chromosome
1p35 and duplication in males disrupts testis differentiation and causes sex reversal, hypospadias,
the presence of Müllerian ducts, and ambiguous external genitalia. Loss of function mutations in
females induces Müllerian aplasia, hyperandrogenism, and SERKAL syndrome, which is
described as female to male sex reversal, gonadal dysgenesis, and developmental problems in the
kidneys, lungs and heart [2,3,17,31]. In conjunction with RSPO1 and β-catenin, WNT4 represses
testicular differentiation and promotes ovarian differentiation by activating the canonical
WNT/β-catenin signaling pathway and initiates FOXL2 transcription. This pathway suppresses
testicular differentiation by preventing the expression of SOX9 and in turn AMH. WNT4 plays
significant roles in ovarian steroidogenesis, oogenesis, and the development of the urogenital
system especially the mesonephros and Müllerian ducts [17,25,32,33,34]. Numerous studies
have observed partial female to male sex reversal in Wnt4 knockout mice indicating that there
are more genes involved in promoting ovarian differentiation and blocking testicular
differentiation. Lack of Müllerian ducts was also observed reiterating Wnt4’s importance in its
development. Double knockout Foxl2 and Wnt4 mice have increased expression of Sox9, Fgf9
and Amh and have a higher degree of sex reversal than just Wnt4 KO mice [21,25,28,35,36].
WNT4 is highly conserved between eutherian mammals and the tammar wallaby; the tammar
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shares 93.2% amino acid homology with humans and has conserved roles in gonadal
development. Consistent with the female tammar developmental timeline, WNT4 expression is
significantly upregulated after day 4 postpartum in comparison to males. XY gonads exposed to
estrogen exhibited sex reversal, decreased expression of SRY, AMH and FGF9, lack of nuclear
SOX9 and increased expression of FOXL2 and WNT4 [16,37,38].
Estrogen Induced Ovarian Development
Several different mouse models have been used to study the effects of estrogen on gonadal
development. Aromatase knockout (ArKO) mice are deficient for the gene CYP19 that encodes
for aromatase, an enzyme that converts androgens to estrogens. αβERKO mice lack both
estrogen receptor 1 (ER1 or ERα) and estrogen receptor 2 (ER2 or ERβ) which mediate estrogen
signaling. Both are required for normal ovarian function and are highly conserved among
vertebrates [11]. Female (XX) mice from both models exhibit an increase in circulating
testosterone, increased expression of genes involved in testicular differentiation, presence of
Sertoli and Leydig cells, and transdifferentiation of the ovary [11,39,40,41]. ArKO mice still
have intact ERs and can be rescued with exogenous estrogen. Estrogen exposure in nonmammalian vertebrates like birds, reptiles, amphibians and fish that follow environmental sex
determination causes male to female sex reversal. This indicates that estrogen is necessary and
sufficient to cause ovarian development in these vertebrates [11,42]. Studies on eutherian
mammals reveal estrogen’s importance in ovarian development and differentiation especially
during folliculogenesis [40,41].
As previously mentioned, exogenous estrogen exposure to the marsupial XY gonad results in
complete sex reversal and ovarian development. Easy accessibility to the tammar pouch young
and gonadal differentiation occurring right after birth allows for exogenous estrogen treatment. A
7

study published in 2010 by Pask et al. explored the effects of estrogen induced ovarian
development in the tammar wallaby. Undifferentiated XY tammar gonads were cultured in the
presence of estrogen. The expression levels of ‘female’ genes WNT4, FOXL2, RSPO1, and FST
and ‘male’ genes SRY, SOX9, AMH, and FGF9 were evaluated in XX gonads and treated and
untreated XY gonads from day 25 prenatal to day 10 postpartum. All these genes involved in
gonadal development are conserved between eutherian and marsupial mammals. During normal
ovarian differentiation, XX gonads had high expression levels of ‘female’ genes around day 4
postpartum and low expression levels of ‘male’ genes. During normal testicular differentiation,
XY gonads had high expression levels of ‘male’ genes around day 1 postpartum and low
expression levels of ‘female’ genes. These high expression time points represent when ovarian
differentiation and testicular differentiation, respectively, occurs during tammar gonadal
development.
As expected, expression levels of genes involved in ovarian differentiation especially WNT4 and
FOXL2 were upregulated and testicular genes were downregulated in the estrogen treated XY
gonads. However, SOX9 expression levels remained the same in both the untreated and treated
estrogen XY gonads. Immunohistochemistry revealed ovarian-like structures such as cortex and
medulla in the treated gonads and lack of testicular cord formation. In addition, SOX9 was found
in the cytoplasmic regions of gonadal cells unlike the control gonads which had nuclear SOX9.
This nuclear exclusion of SOX9 in the estrogen cultured gonads prevents the upregulation of
SOX9 and AMH leading to ovarian development. As previously mentioned, FOXL2 along with
estrogen receptors blocks the expression of SOX9 and AMH to induce ovarian differentiation and
repress testicular differentiation. These findings reveal a potential mechanism by which estrogen
could prevent testicular development and a conserved role of estrogen in vertebrates in thwarting
8

SOX9 nuclear translocation in the ovary. The absence of estrogen results in nuclear SOX9 and
therefore the initiation of testicular development. However, the precise mechanism by which
estrogen prevents nuclear translocation of SOX9 is still unclear [16]. This study offers some
insight into the effects of environmental estrogen exposure on gonadal development and
differentiation in humans.
The tammar wallaby can be used a novel model to understand ovarian development, which is
still poorly understood compared to testicular development. These marsupials can also be used to
define the effects of estrogen on the development of the gonad. Recently, the genome has been
sequenced enhancing the utility of the tammar as a genetic model by Renfree et al. 2010. Due to
the increase in disorders of sexual development in humans, there is a considerable need to
understand gonadal development. Thus, we performed transcriptomics of the normal developing
gonads in both males and females as well as for gonads undergoing estrogen induced sex
reversal. This transcriptome resource will be especially important in identifying novel and
conserved mechanisms of sexual development. This thesis describes the creation, validation and
analyses of these libraries. It also shows that the tammar wallaby is a viable alternative model for
studying gonadal differentiation and the effects of estrogen in sexual development in mammals.
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Table 1. A Selection of Key Genes with Significantly Affected Expression in Sexual
Development in Mammals
Gene
AMH

FOXL2

RSPO1

SOX9

SRY
WNT4

Role(s)
regression of the Müllerian
ducts; supports testicular
differentiation; development
of epididymis, vas deferens,
and seminal vesicle
primordial follicle
development and ovarian
homeostasis; represses
testicular differentiation
activation of WNT/β-catenin
signaling pathway in ovarian
differentiation; represses
testicular differentiation
Sertoli cell development;
promotes testicular
differentiation
initiates and supports
testicular differentiation
activation of WNT/β-catenin
signaling pathway in ovarian
differentiation; represses
testicular differentiation;
oogenesis; ovarian
steroidogenesis; urogenital
development

Human diseases/conditions
Persistent Müllerian duct syndrome,
gonadal dysgenesis, ovotesticular
DSD

References
2,14,15,35,43

Blepharophimosis-Ptosis-Epicanthus 3,23,26,27,28
Inversus Syndrome and premature
ovarian failure, XX sterility
sex reversal, testicular DSD,
palmoplantar hyperkeratosis with
squamous cell carcinoma

2,3,4,18,19,20,
21

Campomelic dysplasia, sex reversal,
gonadal dysgenesis

3,21,25,44,45

sex reversal, gonadal dysgenesis

2,3,5,20,21,31,
46,47
2,3,17,25,31,32,
33,34

SERKAL syndrome, sex reversal,
testicular DSD, Müllerian aplasia,
hyperandrogenism

Materials and Methods
Animals
Tammar wallabies (Macropus eugenii) from Kangaroo Island of South Australia were
maintained in our breeding colony in grassy outdoor enclosures. Fetal sex was determined
through PCR by SRY; pouch young sex was determined through the presence of scrotal bulges or
mammary primordial [48]. Male and female fetal tammar wallaby gonads were dissected and
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snap frozen in liquid nitrogen from fetal day 24, 25, and 26 embryos and from days 0, 1, 2, 4,
and 8 postpartum pouch young. Husbandry, handling and experiments were in accordance with
the National Health and Medical Research Council of Australia (2004) guidelines and approved
by the University of Melbourne Animal Experimentation Ethics Committees.

Treatment of Estradiol in Culture
The gonads were cultured at the University of Melbourne as described as follows. Pairs of
gonadal ridges were cultured from day 25 of gestation from XY-male tammar wallaby fetuses.
The tammar wallaby gonadal ridge first develops on day 21 of the 26.5-day gestation period
[11,16]. Testicular differentiation occurs around day 2 postpartum, and ovarian differentiation
occurs around day 8 postpartum [11,16]. Pairs of gonads were isolated and placed, one into
control media and the other into estrogen media for five days. The control media contained
Dulbecco’s modified Eagle medium (DMEM) with 10% fetal calf serum (FCS) and 50 mg/ml
ampicillin. The estrogen media used the control media with the addition of estradiol benzoate (to
a final concentration of 100 ng/ml). Estradiol benzoate was diluted in 100% ethanol (without
estradiol) was added to control cultures. After five days, the gonads were snap-frozen and stored
at -80°C until needed for RNA extraction.

RNA Extraction
Total RNA was extracted from snap frozen tammar wallaby gonads using the GenEluteTM
Mammalian Total RNA Miniprep Kit (Sigma Cat. no. RTN10) as per manufacturer’s
instructions. Total RNA was DNase treated using the TURBO DNA-freeTM Kit (Ambion Cat. no.
AM1907) as per manufacturer’s instructions. Total RNA was stored at -80°C until needed.
11

Concentrating RNA
The total volume of each RNA sample for each developmental time point and each sex was
pooled and concentrated into 25 µl using the RiboMinusTM Concentration Module (Invitrogen
Cat. no. K1550-05) as per manufacturer’s instructions. Concentrated total RNA was stored at 80°C until needed.

Removal of Ribosomal RNA
Ribosomal RNA was removed from 24 µl of concentrated total RNA using the Ribo-ZeroTM
Magnetic Kit (Human/Mouse/Rat; Epicentre Cat. no. MRZH11124) as per manufacturer’s
instructions. While treating the samples with rRNA Removal Solution, 0.5 µl of 1:10 dilution of
ERCC RNA Spike-In Control Mixes (Ambion Cat. no. 4456740, 4456739) was added to each
sample. After rRNA removal, the samples were purified using the RNeasy MinElute Cleanup Kit
(Qiagen Cat. no. 74204) as per manufacturer’s instructions. The concentration of the sample was
determined using the NanoDrop 1000 Spectrophotometer. Total RNA was stored at -80°C until
needed.

Table 2. List of Samples Used for RNA Sequencing Library
Sample

d24♀
d25♀
d26♀
D0♀
D4♀
D8♀

Number of
gonads
extracted
6
7
8
7
16
6

ERCC RNA
Spike-In
Control Mix
1
2
1
1
2
2

Concentration
(ng/µl)

Amount (µl)

Total RNA
(ng)

10.4
13.2
10.8
16.7
10.8
8.1

9
9
9
9
9
9

93.6
118.8
97.2
150.3
97.2
72.9

12

d24♂
d25♂
d26♂
D0♂
D1♂
D2♂
D4♂
control d25♂
untreated
E2 d25♂
treated

7
9
7
7
6
14
6
6

1
1
1
1
2
1 and 2
2
1

27.5
5.5
12.8
12.2
12.1
13.7
5.9
33.19

11
11
11
11
10
10
10
9

302.5
60.5
140.8
134.2
121
137
59
298.7

6

2

5.63

9

50.7

Note: Samples with a lowercase ‘d’ indicate developmental time points during gestation.
Samples with an uppercase ‘D’ indicate developmental time points postpartum.

Library preparation and sequencing
RNA sequencing and preparation was outsourced to PerkinElmer in Branford, Connecticut. The
Illumina HiSeq 2000 sequencing system was used with HiSeq Flow Cell v3, TruSeq SBS Kit v3,
TruSeq PE Cluster Kit v3-cBot-HS, and TruSeq Multiplex Sequencing Primer Box as per
manufacturer’s instructions.

Data Analysis
FastQC was used to check the quality of the raw high throughput mRNA sequencing reads
obtained from PerkinElmer as per manufacturer’s instructions.
The Bowtie suite published by Trapnell et al. 2012 was used to annotate the transcriptomes,
discover novel genes and to test for differential gene expression. The reads were adapter trimmed
and quality filtered using TrimGalore. Reads that were smaller than 20 bp were discarded. The
samples were then mapped to rRNA sequences using Bowtie2, and the remaining reads were
13

then mapped to an unpublished unannotated tammar assembly as a reference genome using
TopHat2. The aligned reads from TopHat2 were then independently assembled to identify
putative genes using Cufflinks using the option for stranded reads. Cuffmerge was used to merge
the independent assemblies. Genes were identified using BLASTX to search RefSeq, with the
match with the lowest e-value being selected as the identity of the gene. Differentially expressed
genes and transcripts were identified utilizing Cuffdiff. Lastly, CummbeRbund provided
visualized expression data supplied by Cuffdiff [49].
In addition to the Bowtie suite, BLASTX aided in the search for protein coding genes and
Blast2GO annotated the results as per manufacturer’s instructions.

Results
Table 3. Summary of Sequencing Results
Sample
d24♀
d25♀
d26♀
D0♀
D4♀
D8♀
d24♂
d25♂
d26♂
D0♂
D1♂
D2♂
D4♂
control d25♂
untreated
E2 d25♂
treated

Yield (GB)
13.39
13.14
13.88
12.51
15.04
11.69
11.63
14.86
14.53
14.46
12.18
13.14
12.24
14.66

# of Reads (million)
133.9
131.44
138.78
125.14
150.38
116.93
116.28
148.59
145.3
144.62
121.8
131.43
122.41
146.64

% Reads Q >= 30
84.29
84.44
84.4
84.57
85.14
84.79
82.32
82.59
82.46
84.82
84.56
84.69
82.29
81.59

Mean Q Score
33.74
33.79
33.77
33.8
34.01
33.9
33.14
33.24
33.19
33.86
33.8
33.83
33.15
32.93

12.9

128.95

82.16

33.1
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This table summarizes the RNA sequencing results obtained from PerkinElmer using the
Illumina HiSeq 2000 sequencing system. The number of reads for each sample ranged from
116.28 to 146.64 million base pairs. The percentage of those reads with Phred quality score or Q
score of 30 or higher ranged from 81.59 to 85.14. This Q score is used to measure base calling
accuracy. The mean Q score given to each base ranged from 32.93 to 34.01. This indicates that
base call accuracy of this data set is between 99.9 to 99.99% and the probability of incorrect base
call is 1 in 1,000 to 1 in 10,000. This table confirms that this transcriptome data set is very
accurate and should be used for data analysis.

FastQC
Table 4. FastQC Report Basic Statistics
Sample
d24♀
d25♀
d26♀
D0♀
D4♀
D8♀
d24♂
d25♂
d26♂
D0♂
D1♂
D2♂
D4♂
control d25♂ untreated
E2 d25♂ treated

Total Sequences
66950752
65721535
69390000
62548792
75191503
58464804
58137974
74293998
72648754
72310073
60898922
65715502
61203170
73321177
64474138

% Mean GC Content
45
45
45
45
45
45
45
45
45
46
45
46
45
46
46

FastQC was used to check the quality of the raw high throughput mRNA sequencing reads
obtained from PerkinElmer. All sequences were not filtered and sequence length was 100 base
pairs. For every sample, the basic statistic parameters were set by FastQC. Total sequences for
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each sample ranged from 58 to 75 million. The mean percentage of GC content of the sequences
ranges from 45 to 46. High GC content indicates coding regions in these sequences.
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Figure 1. Overall Representation of FastQC Report Quality Scores Across All Bases: (a) E2
d25♂ treated, (b) control d25♂ untreated, (c) D0♂, (d) D0♀

Part (a) of this figure shows a failed per base sequence quality graph according to FastQC.
However, the lack of quality in the first few base pairs of the sequence is normal, and there is not
a huge difference between (a) and all the other parts of the figure. In addition, the low quality
base pairs towards the end of the sequence are expected because of the sequencing chemistry.
Parts (b), (c) and (d) all passed according to FastQC standards. Regardless of FastQC
qualifications of passed and failed data sets, all of the scores are still very good and are within
normal parameters. The difference between passed and failed per base sequence quality graphs is
very slight and is discounted. The blue line in all four figures corresponds to the mean quality
18

score (Q score). These are representative QC reports from control untreated, E2 treated, and
normal male and female gonad samples. All samples showed similar quality scores as the passed
and failed figures shown here.

19

Figure 2. Overall Representation of FastQC Report Quality Score Distribution Across All
Sequences: (a) E2 d25♂ treated, (b) control d25♂ untreated, (c) D0♂, (d) D0♀
20

This figure shows a great representation of the mean sequence quality of each sample. Every
sample passed FastQC's per sequence quality check with average scores around 37 to 38. As
previously mentioned, Q scores are used to measure base calling accuracy. FastQC indicates that
base call accuracy of all samples are between 99.9 to 99.99% and the probability of incorrect
base call is 1 in 1,000 to 1 in 10,000.
From all these FastQC reports, these transcriptomes are of considerable high quality and
accuracy to be utilized for discovering differentially expressed genes and transcripts.

Gene Expression Analyses
Table 5. Potential Gene Targets of Estrogen in Ovarian Development
Gene
DIO1
ABCA5
SDSL
NPHS2
GREB1
IFIT3
CFH

D4 Male
(average FPKM)
−
−
−
8.50532
−
4.18097
−

Control Male
(average FPKM)
34.6153
17.9194
50.3308
14.1093
12.6886
38.064
69.3539

E2 Treated Male
(average FPKM)
122.152
51.80455
129.641
36.0758
27.8067
72.03505
131.191

Upregulation Fold by
Estrogen
3.529
2.891
2.576
2.557
2.191
1.892
1.892

Differential expression is quantified by fragments per kilobase of transcript per million mapped
fragments (FPKM). FPKM is used by Cufflinks and Cuffdiff to standardize expression levels of
each transcript. This takes into consideration the length and abundance of each transcript. Then
FPKM values can be utilized to compare expression levels of different genes and transcripts
[49]. Table 5 lists genes from highest to lowest upregulation fold by estrogen treatment. This
upregulation fold value was obtained by dividing the E2 treated male FPKM values by the
control male FPKM values. These genes are induced by exogenous estrogen treatment and could
21

be potential targets of estrogen during ovarian differentiation. This table provides a glimpse into
novel genes involved in ovarian differentiation. DIO1, ABCA5, and SDSL show the highest
upregulation in differential expression. These genes were further examined in the mouse
GenitoUrinary Development Molecular Anatomy Project (GUDMAP), and show upregulation
during ovarian development in mice in comparison to testes at the same stage. Thus, these genes
are potentially highly conserved mammalian ovarian development factors and are likely to be
estrogen responsive.

Figure 3. Differential Expression Levels of NPHS2 gene
Figure 3 shows an example of significantly changed differential expression of the NPHS2 gene.
The expression level at day 4 postpartum in males is almost equivalent to male gonads cultured
in control media but considerably less than expression levels of male gonads cultured in
estrogen. This figure shows NPHS2 as a potential target of estrogen during ovarian
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differentiation. NPHS2 expression in E2 treated males is induced by exogenous estrogen
treatment and not by culture.

Table 6. Top 10 Changed Gene Expression Levels from Male vs. Female at Each Key
Developmental Stage
Blue indicates genes increased in expression in males while pink shows those increased in
females.
Pre-gonadal
Differentiation
AMH
ALAS2
CALB1
CGA
CLU
CPA1
HBA2
NDNL2
SERPINA3
TMEM52B

During Gonadal
Differentiation
ALAS2
ALDH1A1
CLU
GSTM3
HBA2
NDNL2
PDZK1IP1
RNASEH1
SERPINA3
TNNC1

Post-gonadal
Differentiation
ALAS2
ALDH1A1
CLU
GSTM3
HSD3B1
NDNL2
PTGDS
RNASEH1
SERPINA3
TNNC1

Note: Pre-gonadal differentiation refers to day 24 of gestation to day 2 postpartum in females
and day 24 of gestation to day 0 postpartum in males. During gonadal differentiation refers to
day 4 postpartum in females and day 1 to day 2 postpartum in males. Post-gonadal differentiation
refers to day 8 postpartum in females and day 4 postpartum in males.
This table shows the comparisons male vs. female for each gene listed. Genes shaded in light
blue indicate higher differential expression in males than females. Genes shaded in light pink
indicate higher differential expression in females than males. For example, in comparison to
males, the gene ALAS2 is downregulated in females during all stages of sexual differentiation.
The genes AMH and PTGDS are especially important due to their roles in testicular
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differentiation. AMH is significantly upregulated in males during pre-gonadal differentiation.
PTGDS is significantly upregulated in males during post-gonadal differentiation.

Table 7. Known Testicular and Ovarian Genes with Significant Differential Expression at Each
Stage of Gonadal Differentiation

AMH
DHH
DMRT1
FOXL2
NR0B1
PTGDS
SOX9

♂ pre
↑
↑

♂ during
↑
↑
↑

♂ post
↓

♀ pre
↑

♀ during

♀ post

↑
↑

↑
↑

↑
↑

↑
↓

↑
↑

↑

Note: Pre-gonadal differentiation refers to day 24 of gestation to day 2 postpartum in females
and day 24 of gestation to day 0 postpartum in males. During gonadal differentiation refers to
day 4 postpartum in females and day 1 to day 2 postpartum in males. Post-gonadal differentiation
refers to day 8 postpartum in females and day 4 postpartum in males.
Table 7 indicates whether each gene is upregulated or downregulated during each stage of
gonadal differentiation with an up arrow or a down arrow respectively. AMH, DHH, DMRT1,
PTGDS, and SOX9 all show significant gene expression in males during gonadal differentiation.
This reaffirms their roles in testicular differentiation and validates our transcriptome analyses.
FOXL2 shows significant gene expression in females during gonadal differentiation. This
confirms its role in ovarian differentiation, which is consistent with previous studies in the
tammar, mouse and human, again confirming our transcriptome analyses.
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The genes in the following four figures show very little expression in female wallabies. No
ovaries were collected for day 1 and day 2 postpartum. No testes were collected for day 8
postpartum. There are notable differences in expression levels between females and males.

Figure 4. Differential Expression Levels of AMH gene
AMH expression levels were significantly higher at day 24 of gestation and day 0 postpartum in
males. Levels were low at day 25 of gestation and day 4 postpartum in males. Differential
expression fluctuates in males and is almost nonexistent in females. This figure reiterates this
gene’s role in testicular differentiation.
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Figure 5. Differential Expression Levels of DMRT1 gene
DMRT1 expression levels were significantly higher at day 2 and day 4 postpartum in males.
Levels were low at day 24 and day 25 of gestation. Differential expression is upregulated at a
linear rate. This figure reiterates this gene’s role in testicular differentiation.

Figure 6. Differential Expression of PTGDS gene
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PTGDS expression levels were significantly higher at day 1 and day 4 postpartum in males.
Levels were low at day 24 of gestation. Differential expression is upregulated at a linear rate.
This figure reiterates this gene’s role in testicular differentiation.

Figure 7. Differential Expression of SOX9 gene
SOX9 expression levels were particularly high at day 0 and day 2 postpartum in males. Levels
were low at day 26 of gestation and day 1 and day 4 postpartum in males. Differential expression
fluctuates in males and is almost nonexistent in females. This figure reiterates this gene’s role in
testicular differentiation.

Table 8. Potential Novel Genes Involved in Ovarian and Testicular Differentiation

AFP
ALAS2

Genes
GSTM3
NDNL2
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PDGFA
SERPINA3

These genes were chosen through analyses of FPKM values for all stages of gonadal
differentiation and focused on expression levels during gonadal differentiation for both males
and females. AFP and PDGFA differential expression levels were investigated further.

The genes in the following two figures show very little expression in female wallabies. No
ovaries were collected for day 1 and day 2 postpartum. No testes were collected for day 8
postpartum. There are notable differences in expression levels between females and males.

Figure 8. Differential Expression of AFP gene
AFP expression levels were particularly high at day 25 of gestation and day 1 postpartum in
males. Levels were at its lowest at day 24 of gestation and low at day 26 of gestation in males.
Differential expression essentially plateaus from day 25 of gestation to day 4 postpartum in
males and is almost nonexistent in females.
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Figure 9. Differential Expression of PDGFA gene
PDGFA expression levels were particularly high at day 26 of gestation and peaks on day 0
postpartum in males. Levels were at low at day 24 of gestation in males. Differential expression
is upregulated from day 24 of gestation to day 0 postpartum and is downregulated from day 0 to
day 4 postpartum in males. In females, differential expression stays pretty level.
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Figure 10. Principal Component Analysis (PCA) Graph of Transcriptome Samples
This figure was composed to determine the relationships between each of the transcriptome
samples by grouping them together. There are a few outliers that are especially interesting: day 4
and day 8 females postpartum, E2 treated male and day 1 male postpartum. Day 4 and day 8
females follow a different trajectory than the rest of the samples, which adheres to previous
differential expression studies. E2 treated male also follows a different trajectory and lies close to
day 4 female postpartum. Control male lies close to day 4 male postpartum as expected. During
day 1 male postpartum, the gonad is known to undergo major transcriptional changes since this is
around the time it commits to the testis pathway.
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Functional Annotation and Gene Ontology from Blast2GO

Figure 11. Annotation Results from Blast2GO
This figure was created by Blast2GO. No sequences were without Blast results indicating that all
sequences were processed. There were about 25 thousands sequences without Blast hits after the
BLAST step. There were about five thousand successful sequences with Blast results after the
BLAST step. There were about five thousand successful sequences with mapping results after
the mapping step. There were almost 20 thousand successful sequences that were annotated.
There were 50 thousand sequences entered into Blast2GO for annotation.
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Figure 12. GO-level distribution of Total Annotations from Blast2GO: P = biological process,
F = molecular function, C = cellular component
This figure was created by Blast2GO. It shows the overall distribution of gene ontology terms for
each GO level for 173,830 annotations. A GO level is assigned by Blast2GO and shows the
maximum depth of each GO term. Each term is divided into three different categories: biological
process, molecular function, and cellular component. GO terms are created by the Gene
Ontology Consortium to standardize gene function and product descriptions.

The following tables list GO terms from Blast2GO in their respective categories for genes of
interest.
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Table 9. Gene Ontology Terms for Top Changed Gene Comparisons
Gene
ALAS2

Molecular Function
5-aminolevulinate synthase activity
coenzyme binding
glycine binding
protein binding
pyridoxal phosphate binding

Ras GTPase activator activity
aldehyde dehydrogenase (NAD)
activity
androgen binding
retinal dehydrogenase activity

AMH

Growth factor activity
Hormone activity
Receptor binding
Transforming growth factor beta
receptor binding

APOE

antioxidant activity
beta-amyloid binding
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ALDH1A1

Biological Processes
cellular iron ion homeostasis
erythrocyte differentiation
heme biosynthetic process
hemoglobin biosynthetic process
oxygen homeostasis
porphyrin-containing compound metabolic
process
protoporphyrinogen IX biosynthetic process
response to hypoxia
small molecule metabolic process
cellular aldehyde metabolic process
ethanol oxidation
positive regulation of Ras GTPase activity
retinol metabolic process
small molecule metabolic process
xenobiotic metabolic process
Müllerian duct regression
Aging
Cell-cell signaling
Gonadal mesoderm development
Positive regulation of: NF-kappaB
transcription factor activity, gene expression
Preantral ovarian follicle growth
Response to: drug, organic cyclic compound
Sex determination
Sex differentiation
Urogenital system development
G-protein coupled receptor signaling pathway
N-methyl-D-aspartate receptor clustering

Cellular Component
mitochondrial inner
membrane
mitochondrial matrix
mitochondrion

cytoplasm
cytosol
extracellular vesicular
exosome

Cytoplasm
Extracellular region
Extracellular space

Golgi apparatus
blood microparticle
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cholesterol transporter activity
heparin binding
hydroxyapatite binding
identical protein binding
lipid binding
lipid transporter activity
lipoprotein particle binding
low-density lipoprotein particle
receptor binding
metal chelating activity
phosphatidylcholine-sterol Oacyltransferase activator activity
phospholipid binding
protein binding
protein homodimerization activity
tau protein binding
very-low-density lipoprotein
particle receptor binding

aging
alpha-amino-3-hydroxy-5-methyl-4-isoxazole
propionate selective glutamate receptor
clustering
artery morphogenesis
cGMP-mediated signaling
cell death
cellular calcium ion homeostasis
cellular response to: cholesterol, growth factor
stimulus, interleukin-1
cholesterol: catabolic process, efflux,
homeostasis, metabolic process
chylomicron remnant clearance
cytoskeleton organization
fatty acid homeostasis
high-density lipoprotein particle: assembly,
clearance, remodeling
intracellular transport
lipoprotein biosynthetic process
lipoprotein catabolic process
lipoprotein metabolic process
long-chain fatty acid transport
low-density lipoprotein particle remodeling
maintenance of location in cell
negative regulation of: MAP kinase activity,
beta-amyloid formation, blood coagulation,
blood vessel endothelial cell migration,
cholesterol biosynthetic process, cholesterol
efflux, dendritic spine development, dendritic
spine maintenance, endothelial cell
proliferation, inflammatory response, lipid
biosynthetic process, lipid transport across

chylomicron
cytoplasm
dendrite
early endosome
endocytic vesicle lumen
extracellular matrix
extracellular region
extracellular space
extracellular vesicular
exosome
extrinsic component of
external side of plasma
membrane
high-density lipoprotein
particle
intermediate-density
lipoprotein particle
late endosome
low-density lipoprotein
particle
membrane
neuronal cell body
nucleus
plasma membrane
very-low-density lipoprotein
particle
vesicle
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blood brain barrier, neuron apoptotic process,
neuron death, phospholipid efflux, platelet
activation, postsynaptic membrane
organization, presynaptic membrane
organization
nitric oxide mediated signal transduction
oligodendrocyte differentiation
peripheral nervous system axon regeneration
phospholipid efflux
phototransduction, visible light
positive regulation of: axon extension, betaamyloid formation, cGMP biosynthetic
process, cholesterol efflux, cholesterol
esterification, dendritic spine development,
dendritic spine maintenance, lipid biosynthetic
process, lipid transport across blood brain
barrier, low-density lipoprotein particle
receptor catabolic process, membrane protein
ectodomain proteolysis, neurofibrillary tangle
assembly, neuron death, nitric-oxide synthase
activity, phospholipid efflux, postsynaptic
membrane organization, presynaptic
membrane organization
protein import
receptor-mediated endocytosis
regulation of: Cdc42 protein signal
transduction, axon extension, beta-amyloid
clearance, neuron death, neuronal synaptic
plasticity, tau-protein kinase activity
response to: dietary excess, ethanol, insulin,
reactive oxygen species, retinoic acid
retinoid metabolic process

C5L2 anaphylatoxin chemotactic
receptor binding
endopeptidase inhibitor activity
protein binding
receptor binding

CA3

carbonate dehydratase activity
nickel cation binding
zinc ion binding
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C3

CALB1

calcium ion binding

reverse cholesterol transport
small molecule metabolic process
synaptic transmission, cholinergic
triglyceride metabolic process
vasodilation
very-low density lipoprotein clearance
very-low density lipoprotein remodeling
G-protein coupled receptor signaling pathway
complement activation
complement activation, alternative pathway
complement activation, classical pathway
fatty acid metabolic process
immune response
inflammatory response
innate immune response
negative regulation of endopeptidase activity
positive regulation of: G-protein coupled
receptor protein signaling pathway, activation
of membrane attack complex, angiogenesis,
apoptotic cell clearance, glucose transport,
lipid storage, protein phosphorylation, type IIa
hypersensitivity, vascular endothelial growth
factor production
regulation of: complement activation, immune
response, triglyceride biosynthetic process
signal transduction
bicarbonate transport
one-carbon metabolic process
response to ethanol
response to oxidative stress
small molecule metabolic process
cellular response to organic substance

blood microparticle
extracellular region
extracellular space
extracellular vesicular
exosome
plasma membrane

Cytosol

Axon

protein binding
vitamin D binding
zinc ion binding

serine-type endopeptidase activity
serine-type peptidase activity

CGA

hormone activity
protein binding
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CFD

cytosolic calcium ion homeostasis
locomotory behavior
long-term memory
metanephric collecting duct development
metanephric connecting tubule development
metanephric distal convoluted tubule
development
metanephric part of ureteric bud development
regulation of synaptic plasticity
retina layer formation
short-term memory
blood coagulation
complement activation
complement activation, alternative pathway
innate immune response
platelet activation
platelet degranulatioon
proteolysis
cell-cell signaling
cellular protein metabolic process
cellular response to hormone stimulus
developmental growth
follicle-stimulating hormone secretion
gonad development
luteinizing hormone secretion
negative regulation of organ growth
peptide hormone processing
positive regulation of cell migration
positive regulation of cell proliferation
positive regulation of transcription from RNA
polymerase II promoter
signal transduction

cytosol
dendrite
extracellular vesicular
exosome
neuronal cell body
nucleus synapse

extracellular region
extracellular space
extracellular vesicular
exosome
platelet alpha granule lumen

Extracellular region

CLU

NOT ATPase activity
misfolded protein binding
protein binding
ubiquitin protein ligase binding
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thyroid gland development
thyroid hormone generation
blood coagulation
cell morphogenesis
central nervous system myelin maintenance
chaperone-mediated protein complex
assembly
chaperone-mediated protein folding
complement activation
complement activation, classical pathway
innate immune response intrinsic apoptotic
signaling pathway
lipid metabolic process
microglial cell activation
microglial cell proliferation
negative regulation of beta-amyloid formation
negative regulation of intrinsic apoptotic
signaling pathway in response to DNA
damage
negative regulation of protein
homooligomerization
platelet activation
platelet degranulation
positive regulation of: NF-kappaB
transcription factor activity, apoptotic process,
beta-amyloid formation, intrinsic apoptotic
signaling pathway
positive regulation of neurofibrillary tangle
assembly, neuron death, nitric oxide
biosynthetic process, proteasomal ubiquitindependent protein catabolic process, tauprotein kinase activity, tumor necrosis factor

apical dendrite
blood microparticle
chromaffin granule
cytoplasm
cytosol
endoplasmic reticulum
extracellular matrix
colocalizes with
extracellular matrix
extracellular region
extracellular space
extracellular vesicular
exosome
mitochondrial membrane
mitochondrion
neurofibrillary tangle
nucleus
perinuclear region of
cytoplasm
platelet alpha granule lumen
spherical high-density
lipoprotein particle

CPA1
CTRB2

Metallocarboxypeptidase activity
Zinc ion binding
serine-type endopeptidase activity
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DIO1

GSTM3

selenium binding
thyroxine 5’-deiodinase activity

enzyme binding
glutathione binding
glutathione transferase activity
identical protein binding
protein homodimerization activity

production
protein import
protein stabilization
regulation of: beta-amyloid clearance, neuron
death, neuronal signal transduction
release of cytochrome c from mitochondria
response to misfolded protein
response to virus
reverse cholesterol transport
proteolysis
cobalamin metabolic process
digestion
extracellular matrix disassembly
extracellular matrix organization
proteolysis
small molecule metabolic process
vitamin metabolic process
water-soluble vitamin metabolic process
Cellular nitrogen compound metabolic process
hormone biosynthetic process
oxidation-reduction process
small molecule metabolic process
thyroid hormone generation
cellular detoxification of nitrogen compound
establishment of blood-nerve barrier
glutathione derivative biosynthetic process
glutathione metabolic process
nitrobenzene metabolic process
response to estrogen
small molecule metabolic process
xenobiotic catabolic process

Extracellular space
extracellular region
extracellular space

endoplasmic reticulum
membrane
integral component of
membrane
plasma membrane
Cytoplasm
cytosol
extracellular vesicular
exosome
nucleus
sperm fibrous sheath

HBA2

Contributes to haptoglobin binding
heme binding
iron ion binding
oxygen binding
oxygen transporter activity
contributes to peroxidase activity
protein binding

xenobiotic metabolic process
Biocarbonate transport
Hydrogen peroxide catabolic process
Oxidation-reduction process
Oxygen transport
Positive regulation of cell death
Protein heterooligomerization
Response to hydrogen peroxide
Small molecular metabolic process

3-beta-hydroxy-delta5-steroid
dehydrogenase activity
Steroid delta-isomerase activity

androgen biosynthetic process
estrogen biosynthetic process
glucocorticoid biosynthetic process
mineralocorticoid biosynthetic process
oxidation-reduction process
small molecule metabolic process
steroid biosynthetic process
steroid metabolic process

IGFBP3

fibronectin binding
insulin-like growth factor I binding
insulin-like growth factor binding
metal ion binding
protein binding
protein tyrosine phosphatase
activator activity

apoptotic process
cellular protein metabolic process
negative regulation of: cell proliferation,
protein phosphorylation, signal transduction,
smooth muscle cell migration, smooth muscle
cell proliferation
osteoblast differentiation
positive regulation of: MAPK cascade,
apoptotic process, catalytic activity, insulin-
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HSD3B1

Blood microparticle
cytosol
cytosolic small ribosomal
subunit
endocytic vesicle lumen
extracellular region
extracellular vesicular
exosome
haptoglobin-hemoglobin
complex
hemoglobin complex
membrane
endoplasmic reticulum
membrane
integral component of
membrane
mitochondrial inner
membrane
mitochondrial
intermembrane space
smooth endoplasmic
reticulum membrane
extracellular region
extracellular space
extracellular vesicular
exosome
insulin-like growth factor
binding protein complex
nucleus

MGP

NDNL2

calcium ion binding
extracellular matrix structural
constituent
structural constituent of bone

like growth factor receptor signaling pathway,
myoblast differentiation
protein phosphorylation
regulation of cell growth
regulation of glucose metabolic process
type B pancreatic cell proliferation
cartilage condensation
cell differentiation
ossification
regulation of bone mineralization

DNA recombination
DNA repair
positive regulation of protein ubiquitination
regulation of growth

Fatty acid binding
Prostaglandin-D synthase activity
Retinoid binding
Transporter activity

Arachidonic acid metabolic process
Cyclooxygenase pathway
Prostaglandin biosynthetic process
Regulation of circadian sleep/wake cycle,
sleep
Response to glucocorticoid
Small molecule metabolic process
transport
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Protein binding

PDZK1IP1

PTGDS

colocalizes with
extracellular matrix
extracellular vesicular
exosome
proteinaceous extracellular
matrix
Smc5-Smc6 complex
Chromosome, telomeric
region
Cytoplasm
nucleus
Extracellular vesicular
exosome
Integral component of
membrane
Golgi apparatus
Endoplasmic reticulum
membrane
Extracellular region
Extracellular space
Extracellular vesicular
exosome
Nuclear membrane
Perinuclear region of
cytoplasm
Rough endoplasmic

RNASEH1

SAA1

RNA binding
RNA-DNA hybrid ribonuclease
activity
Magnesium ion binding
Nucleic acid binding
Protein homodimerization activity
Ribonuclease activity
G-protein coupled receptor binding
heparin binding
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SERPINA3

DNA binding
protein binding
serine-type endopeptidase inhibitor
activity

RNA catabolic process
RNA phosphodiester bond hydrolysis
RNA phosphodiester bond hydrolysis,
endonucleolytic
Mitochondrial DNA replication

acute-phase response
innate immune response
lymphocyte chemotaxis
macrophage chemotaxis
negative regulation of inflammatory response
neutrophil chemotaxis
platelet activation
positive regulation of: cell adhesion, cytokine
secretion, cytosolic calcium ion concentration,
interleukin-1 secretion
acute-phase response
inflammatory response
maintenance of gastrointestinal epithelium
negative regulation of endopeptidase activity
regulation of lipid metabolic process
regulation of proteolysis

TMEM52B

TNNC1

actin filament binding
calcium ion binding
calcium-dependent protein binding

cardiac muscle contraction
diaphragm contraction
muscle filament sliding

reticulum
Mitochondrion
nucleus

endocytic vesicle lumen
extracellular region
extracellular vesicular
exosome
high-density lipoprotein
particle

blood microparticle
extracellular region
extracellular space
extracellular vesicular
exosome
intracellular
nucleus
extracellular vesicular
exosome
integral component of
membrane
actin cytoskeleton
cytosol
mitochondrion

protein binding
protein homodimerization activity
troponin I binding
troponin T binding

regulation of ATPase activity
regulation of muscle contraction
regulation of muscle filament sliding speed
response to metal ion
ventricular cardiac muscle tissue
morphogenesis

NOT nucleolus
nucleus
troponin complex

Table 10. Gene Ontology Terms for Potential Novel Genes
Gene
AFP

43

PDGFA

Molecular Function
metal ion binding

Collagen binding
Growth factor activity
Platelet-derived growth factor
binding
Platelet-derived growth factor
receptor binding
Contributes to platelet-derived
growth factor receptor binding
Platelet-derived growth factor
receptor binding
Protein binding
Protein heterodimerization activity
Protein homodimerization activity

Biological Processes
SMAD protein signal transduction
ovulation from ovarian follicle
progesterone metabolic process
transport
Fc-epsilon receptor signaling pathway
Actin cytoskeleton organization
Angiogenesis
Blood coagulation
Cell activation
Cell projection assembly
Cell-cell signaling embryo development
Epidermal growth factor receptor signaling
pathway
Extracellular matrix organization
Fibroblast growth factor receptor signaling
pathway
Hair follicle development
Innate immune response
Inner ear development
Lung alveolus development
Negative chemotaxis

Cellular Component
Cytoplasm
extracellular space

Golgi membrane
Cell surface
Endoplasmic reticulum
lumen
Extracellular region
Extracellular space
Microvillus
Platelet alpha granule lumen
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Negative regulation of phosphatidylinositol
biosynthetic process
Negative regulation of platelet activation
Neurotrophin TRK receptor signaling pathway
Organ morphogenesis
Phosphatidylinositol-mediated signaling
Platelet activation
Platelet degranulation
Platelet-derived growth factor receptor
signaling pathway
Positive regulation of: DNA replication, ERK1
and ERK2 cascade, MAP kinase activity,
MAPK cascade, cell division, cell migration,
cell proliferation, fibroblast proliferation,
mesenchymal cell proliferation, metanephric
mesenchymal cell migration by platelet-derived
growth factor receptor-beta signaling pathway,
phosphatidylinositol 3-kinase signaling, protein
autophosphorylation, protein kinase B signaling
NOT regulation of DNA biosynthetic process
Regulation of actin cytoskeleton organization
Regulation of branching involved in salivary
gland morphogenesis by epithelialmesenchymal signaling
NOT regulation of glomerular mesangial cell
proliferation
Regulation of pepitdyl-tyrosine
phosphorylation
Regulation of smooth muscle cell migration
Response to: drug, estradiol, hypoxia,
substance, retinoic acid, wounding
Skin development

Transforming growth factor beta receptor
signaling pathway
Wound healing
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Discussion
There is a tremendous need for comparative transcriptome analyses focusing on mammalian
sexual development. Even though there is a vast amount of knowledge on this subject, many
aspects of gonadal differentiation, especially ovarian development, have yet to be discovered.
This thesis presents an important new comparative resource for the sex determination community
with the analyses of high-depth transcriptomes during marsupial gonadal development. Due to
time constraints, the vast amount of work went into extensive RNA sample prep and QC, and
there was only a limited amount of time for data analyses. Even though the data analyses are
rather rudimentary at this stage, results confirm previous findings on sexual differentiation,
validating the utility of this data set. Analyses also revealed novel gene information and
uncovered novel pathways induced by exogenous estrogen exposure.
Testicular development in the tammar wallaby occurs during day 1 and day 2 postpartum.
However, ovarian development occurs around day 4 postpartum at the molecular level and
around day 8 postpartum histologically. Due to the window of time in which gonads were
collected for these analyses, most of the differential expression data obtained pertains to genes
involved in the testicular developmental pathway. Nevertheless, analyses did reveal significant
upregulation of differential expression levels of FOXL2 in females during day 4 postpartum,
which is during ovarian differentiation. This reaffirms the conserved role of FOXL2 in ovarian
differentiation in mice, humans, and the tammar wallaby and its noninvolvement in testicular
differentiation [16,24,29]. There was significant upregulation of differential expression of desert
hedgehog (DHH), during day 1 postpartum in males, which is during testicular differentiation.
This data is consistent with previous research stating the importance of DHH in testicular
differentiation especially the early development of Leydig cells in mice and humans. In addition,
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it confirms the conserved role of DHH in the tammar wallaby and eutherian mammals in the
male gonadal pathway [10,17,21]. Nuclear receptor subfamily 0, group B, member 1 (NR0B1)
was upregulated during day 24 of gestation in females. The role of NR0B1 during gonadal
differentiation is unclear due to its characteristic of acting in a dose-dependent manner in mice
and humans [3,9,15,36]. Previous studies have opposing views on whether it plays any role in
gonadal development and whether it has roles in both testicular and ovarian differentiation
[14,15,25]. Unlike mice and humans, NR0B1 is located on autosomal chromosome 5 in the
tammar wallaby and not on the X-chromosome [14,17]. This gene can act as a pro-ovary gene
consistent with its early upregulation in the ovary in the tammar. Nevertheless, more studies need
to be done to clarify NR0B1’s role in sexual differentiation.
Table 7 and Figure 4 show considerable differential expression levels of AMH throughout each
stage of testicular differentiation and during pre-ovarian differentiation. These figures
recapitulate the conserved importance of AMH in supporting male urogenital differentiation and
development [2,17,44,50]. Furthermore, these data corroborate those seen previously for AMH in
the tammar wallaby [16]. Results also revealed significant upregulation of doublesex and mab-3
related transcription factor 1 (DMRT1) in males, especially from day 26 of gestation to day 4
postpartum growing at an increasing rate. Prior studies indicate that DMRT1 upregulation in
males is highly conserved among all vertebrates in the testes, and show it has a vital role in mice
during postnatal testicular differentiation [15,25,28,30]. These studies are consistent with
expression levels found in the tammar wallaby and highlight the relevance of this gene in male
development in all vertebrates including the tammar. Similarly to DMRT1, the expression levels
of PTGDS, prostaglandin D2 synthase, increased at linear rate in males. This follows with
research on the importance of PTGDS in testicular differentiation and the development of Sertoli
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cells [21,36,47]. Lastly, SOX9 is differentially expressed during all stages of male gonadal
differentiation and is barely expressed in females. This data stresses the established and
conserved role of SOX9 in promoting testicular formation and differentiation in all vertebrates
including the tammar wallaby [1,9,14,21,28,45,47]. Previous studies done on the tammar
wallaby show similar expression patterns, which reiterates this gene’s role conservation in
eutherians and marsupials [15,16,45]. Taken together, these analyses validate the transcriptomes
as a viable resource and a great representation of key sexual differentiation genes.
Besides known sexual differentiation data, information on potential novel genes involved in
gonadal differentiation in the tammar wallaby can be obtained from expression analyses. Based
on analyses of significant expression levels during periods of testicular and ovarian
differentiation, a list of potential novel genes was attained. These include AFP, ALAS2, GSTM3,
NDNL2, PDGFA, and SERPINA3. For instance in Figure 9, platelet-derived growth factor
subunit A (PDGFA) had substantially high expression levels during testicular differentiation and
low levels in females. This indicates the likelihood of PDGFA being relevant in male gonadal
development. A few studies briefly mention PDGF and PDGFA potentially being part of SOX9
localization and the development of Leydig cells [21,25,47,51]. Moreover in Figure 8, alphafetoprotein (AFP) also had particularly high expression levels during all stages of male gonadal
differentiation and very low levels in females especially during ovarian differentiation. This data
illustrates the prospect of AFP being a component of the male developmental pathway. None of
the GO terms listed in Table 10 indicate any role in gonadal development for AFP and PDGFA.
More studies such as immunohistochemistry need to be done for both PDGFA and AFP to
confirm their importance in testicular differentiation.
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Additionally, differential expression data were obtained from male gonads cultured in control
media and in estrogen media. Preliminary data suggest that a plethora of genes were affected by
exogenous estrogen exposure. In comparison to expression levels of gonads treated with control
media, various genes were upregulated and downregulated on many levels due to exogenous
estrogen exposure. These genes could potentially play a significant part of gonadal
differentiation and could provide clues to how exogenous estrogen can activate estrogen
receptors leading to the ovarian phenotype. As previously mentioned, exogenous estrogen
exposure of the marsupial XY gonad results in complete sex reversal and ovarian development.
Both estrogen receptors in the tammar are shown have a high degree of sequence homology to
humans, mice and other vertebrates [11]. Therefore, further analyses can be performed on mice
and humans to verify the effects of exogenous estrogen on the expression levels of the affected
genes and their relevance in sexual differentiation. Many of the genes I identified to be
upregulated in the estrogen cultured gonad were also known to be significantly differentially
expressed and upregulated during ovarian development in the mouse (using GUDMAP). Such
genes are highly conserved and are novel factors in the female developmental pathway that will
form the topic of future investigations in the development of the mammalian ovary.
Although a great deal of information was obtained, there are limitations to how much insight the
initial data analyses will reveal about ovarian differentiation. Despite the enormous coverage of
the reference tammar wallaby genome, there are some reads from the created transcriptomes that
will not be mappable. To reduce the amount of unmapped reads, the genomes of two other
marsupials, the opossum and Tasmanian devil, can be used to aid in read annotation, as well as
the human and mouse genomes. However, it will only align those reads that are highly conserved
across these species. In addition, the gene SRY was not able to be pulled from the data analyses
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due to different alignment tools calling it different genes. This could potentially be the case for
other divergent genes that could not be mapped. A new annotation of the tammar genome is
pending release in 2015 and will significantly improve the utility of this data in future analyses.
Furthermore, the data analyses only provides information about tammar wallaby transcriptomes
and therefore more work will need to be done to create transcriptomes for the aromatase
knockout mouse (ArKO) and the human cell line NT2/D1. The current tammar transcriptomes
described in this thesis show normal gonadal development, the effects of estrogen in the gonad,
and mentions some possible targets of environmental endocrine disrupters (EEDs) in the gonads.
However, the specific interests of this thesis pertain to genes that are somatic cell specific
meaning the supporting cell lineage and totipotent germ cells of the ovary and testis. NT2/D1 is a
human pluripotent embryonal carcinoma cell line that was found to express both estrogen
receptors, to be an excellent model for male gonadal development, express SRY and SOX9, and
can respond to exogenous estrogen [5,52]. By developing transcriptomes with exogenous
estrogen treatment in the tammar wallaby, NT2/D1 cell line and ARKO mouse, developmental
researchers can perform comparative analyses to isolate somatic cell specific estrogen responsive
genes. From those studies, potential genes involved in mammalian ovarian differentiation that
trigger disorders of sexual development (DSDs), and are targets of estrogenic EEDs could be
discovered. With this valuable data, prospective treatments could possibly be developed to treat
DSDs and prevent future exposure of humans to EEDs.
Conclusion
The tammar wallaby, Macropus eugenii, is a novel and important new genetic model for research
in human development especially sex determination and sexual differentiation. With the ever
increasing rate and occurrence of disorders of sexual development (DSDs), comparative studies
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such as this one are going to be critical in determining the key events in sexual differentiation in
all mammals including humans. Transcriptomes from this study could potentially lead to
treatments for DSDs and reveal new information about ovarian differentiation in mammals.
These results show a lot of similarities, but also some interesting differences from mouse and
human studies. Overall, this is a viable transcriptome resource and a good comparative data set
to uncover conserved and novel genes regulating mammalian gonad formation. This thesis
provides the first transcriptome analyses investigating the role of estrogen in sex reversal in the
mammalian gonad.
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